580 related articles for article (PubMed ID: 19501389)
1. A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.
Hu X; Macdonald DM; Huettner PC; Feng Z; El Naqa IM; Schwarz JK; Mutch DG; Grigsby PW; Powell SN; Wang X
Gynecol Oncol; 2009 Sep; 114(3):457-64. PubMed ID: 19501389
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection.
Patnaik SK; Kannisto E; Knudsen S; Yendamuri S
Cancer Res; 2010 Jan; 70(1):36-45. PubMed ID: 20028859
[TBL] [Abstract][Full Text] [Related]
3. Role of microRNAs in drug-resistant ovarian cancer cells.
Sorrentino A; Liu CG; Addario A; Peschle C; Scambia G; Ferlini C
Gynecol Oncol; 2008 Dec; 111(3):478-86. PubMed ID: 18823650
[TBL] [Abstract][Full Text] [Related]
4. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.
Fulci V; Colombo T; Chiaretti S; Messina M; Citarella F; Tavolaro S; Guarini A; Foà R; Macino G
Genes Chromosomes Cancer; 2009 Dec; 48(12):1069-82. PubMed ID: 19760605
[TBL] [Abstract][Full Text] [Related]
5. Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients.
Eitan R; Kushnir M; Lithwick-Yanai G; David MB; Hoshen M; Glezerman M; Hod M; Sabah G; Rosenwald S; Levavi H
Gynecol Oncol; 2009 Aug; 114(2):253-9. PubMed ID: 19446316
[TBL] [Abstract][Full Text] [Related]
6. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH
Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.
Corney DC; Flesken-Nikitin A; Godwin AK; Wang W; Nikitin AY
Cancer Res; 2007 Sep; 67(18):8433-8. PubMed ID: 17823410
[TBL] [Abstract][Full Text] [Related]
8. miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer.
Gallardo E; Navarro A; Viñolas N; Marrades RM; Diaz T; Gel B; Quera A; Bandres E; Garcia-Foncillas J; Ramirez J; Monzo M
Carcinogenesis; 2009 Nov; 30(11):1903-9. PubMed ID: 19736307
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer.
Raponi M; Dossey L; Jatkoe T; Wu X; Chen G; Fan H; Beer DG
Cancer Res; 2009 Jul; 69(14):5776-83. PubMed ID: 19584273
[TBL] [Abstract][Full Text] [Related]
10. 5-Fluorouracil and oxaliplatin modify the expression profiles of microRNAs in human colon cancer cells in vitro.
Zhou J; Zhou Y; Yin B; Hao W; Zhao L; Ju W; Bai C
Oncol Rep; 2010 Jan; 23(1):121-8. PubMed ID: 19956872
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells.
Takakura S; Mitsutake N; Nakashima M; Namba H; Saenko VA; Rogounovitch TI; Nakazawa Y; Hayashi T; Ohtsuru A; Yamashita S
Cancer Sci; 2008 Jun; 99(6):1147-54. PubMed ID: 18429962
[TBL] [Abstract][Full Text] [Related]
12. CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis.
Guled M; Lahti L; Lindholm PM; Salmenkivi K; Bagwan I; Nicholson AG; Knuutila S
Genes Chromosomes Cancer; 2009 Jul; 48(7):615-23. PubMed ID: 19396864
[TBL] [Abstract][Full Text] [Related]
13. The miR-200 family controls beta-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients.
Leskelä S; Leandro-García LJ; Mendiola M; Barriuso J; Inglada-Pérez L; Muñoz I; Martínez-Delgado B; Redondo A; de Santiago J; Robledo M; Hardisson D; Rodríguez-Antona C
Endocr Relat Cancer; 2011 Feb; 18(1):85-95. PubMed ID: 21051560
[TBL] [Abstract][Full Text] [Related]
14. microRNA expression profile in undifferentiated gastric cancer.
Katada T; Ishiguro H; Kuwabara Y; Kimura M; Mitui A; Mori Y; Ogawa R; Harata K; Fujii Y
Int J Oncol; 2009 Feb; 34(2):537-42. PubMed ID: 19148490
[TBL] [Abstract][Full Text] [Related]
15. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform.
Resnick KE; Alder H; Hagan JP; Richardson DL; Croce CM; Cohn DE
Gynecol Oncol; 2009 Jan; 112(1):55-9. PubMed ID: 18954897
[TBL] [Abstract][Full Text] [Related]
16. [Cloning and identification of microRNA from human osteosarcoma cell line SOSP-9607].
Gao J; Yang TT; Qiu XC; Yu B; Han JW; Fan QY; Ma BA
Ai Zheng; 2007 Jun; 26(6):561-5. PubMed ID: 17562257
[TBL] [Abstract][Full Text] [Related]
17. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells.
Bandres E; Bitarte N; Arias F; Agorreta J; Fortes P; Agirre X; Zarate R; Diaz-Gonzalez JA; Ramirez N; Sola JJ; Jimenez P; Rodriguez J; Garcia-Foncillas J
Clin Cancer Res; 2009 Apr; 15(7):2281-90. PubMed ID: 19318487
[TBL] [Abstract][Full Text] [Related]
18. microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs.
Xia H; Qi Y; Ng SS; Chen X; Li D; Chen S; Ge R; Jiang S; Li G; Chen Y; He ML; Kung HF; Lai L; Lin MC
Brain Res; 2009 May; 1269():158-65. PubMed ID: 19265686
[TBL] [Abstract][Full Text] [Related]
19. The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma.
Chow TF; Mankaruos M; Scorilas A; Youssef Y; Girgis A; Mossad S; Metias S; Rofael Y; Honey RJ; Stewart R; Pace KT; Yousef GM
J Urol; 2010 Feb; 183(2):743-51. PubMed ID: 20022054
[TBL] [Abstract][Full Text] [Related]
20. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation.
Cho WC; Chow AS; Au JS
Eur J Cancer; 2009 Aug; 45(12):2197-206. PubMed ID: 19493678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
